New Drug Treats All Genotypes of Chronic HCV.
作者信息
Aschenbrenner Diane S
机构信息
Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch:
出版信息
Am J Nurs. 2016 Oct;116(10):27. doi: 10.1097/01.NAJ.0000503296.12853.3e.
Abstract
摘要
相似文献
1
New Drug Treats All Genotypes of Chronic HCV.
Am J Nurs. 2016 Oct;116(10):27. doi: 10.1097/01.NAJ.0000503296.12853.3e.
2
Sofosbuvir/velpatasvir (Epclusa) for hepatitis C.
Med Lett Drugs Ther. 2016 Aug 15;58(1501):107-8.
3
Sofosbuvir/Velpatasvir (Epclusa) for Hepatitis C.
Am Fam Physician. 2017 May 15;95(10):664-666.
4
Mavyret and Vosevi--two new combinations for chronic HCV infection.
Med Lett Drugs Ther. 2017 Oct 9;59(1531):166-170.
5
Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir.
Hepatology. 2016 Sep;64(3):983-5. doi: 10.1002/hep.28636. Epub 2016 Jun 14.
6
Sofosbuvir, velpatasvir and voxilaprevir combination therapy for treating patients with hepatitis C virus infection.
Drugs Today (Barc). 2018 Apr;54(4):255-268. doi: 10.1358/dot.2018.54.4.2788017.
7
Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.
Ann Intern Med. 2015 Dec 1;163(11):818-26. doi: 10.7326/M15-1000. Epub 2015 Nov 10.
8
Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment.
J Gastroenterol Hepatol. 2018 Dec;33(12):2029-2036. doi: 10.1111/jgh.14301. Epub 2018 Jun 25.
9
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.
Ann Intern Med. 2015 Dec 1;163(11):809-17. doi: 10.7326/M15-1014. Epub 2015 Nov 10.
10
Sofosbuvir and velpatasvir for the treatment of hepatitis C.
Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):501-505. doi: 10.1080/17474124.2017.1326817. Epub 2017 May 11.
Zotero 插件